SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$44,000
+22.2%
41,574
-3.1%
0.00%0.0%
Q4 2021$36,000
-54.4%
42,900
-27.9%
0.00%0.0%
Q3 2021$79,000
-37.3%
59,500
-10.0%
0.00%
-50.0%
Q2 2021$126,00066,1000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,125,585$9,480,0007.68%
DAFNA Capital Management LLC 1,204,825$5,374,0001.28%
Psagot Value Holdings Ltd. 3,095,741$13,807,0000.31%
Ground Swell Capital, LLC 14,684$65,0000.21%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 445,171$1,985,000,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,591$1,350,0000.02%
Phoenix Holdings Ltd. 244,113$1,089,0000.02%
Virtu Financial LLC 27,744$124,0000.01%
D.A. DAVIDSON & CO. 130,700$583,0000.01%
Schonfeld Strategic Advisors LLC 89,278$399,0000.01%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders